advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (101)
Showing records 1 to 25
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation72896 Ocular Cubosome Drug Delivery System for Timolol Maleate: Preparation, Characterization, Cytotoxicity, Ex Vivo, and In Vivo Evaluation
Huang J
AAPS PharmSciTech 2017; 18: 2919-2926
72720 Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost
Martinez-de-la-Casa JM
Ocular Surface 2017; 15: 723-729
72916 Pharmacokinetics and Safety of Travoprost 0.004% Ophthalmic Solution Preserved with Polyquad in Pediatric Patients with Glaucoma
Stahl E
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 361-365
73001 Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction
Natesan S
International Journal of Biological Macromolecules 2017; 104: 1837-1845
72837 Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure
Ling TE
Open Ophthalmology Journal 2017; 11: 31-39
71955 Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles
Sánchez-López E
European Journal of Pharmaceutics and Biopharmaceutics 2017; 110: 58-69
72747 Switching to preservative-free latanoprost: impact on tolerability and patient satisfaction
Muñoz Negrete FJ
Clinical Ophthalmology 2017; 11: 557-566
72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Adelli GR
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179
72967 Efficacy and tolerability of preservative-free 0.0015% tafluprost in glaucoma patients: a prospective crossover study
Lee W
BMC Ophthalmology 2017; 17: 61
72910 Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide
Morsi N
European Journal of Pharmaceutical Sciences 2017; 104: 302-314
72940 The Eye Drop Preservative Benzalkonium Chloride Potently Induces Mitochondrial Dysfunction and Preferentially Affects LHON Mutant Cells
Datta S
Investigative Ophthalmology and Visual Science 2017; 58: 2406-2412
72633 Creation of nano eye-drops and effective drug delivery to the interior of the eye
Ikuta Y
Scientific reports 2017; 7: 44229
73010 RES-loaded pegylated CS NPs: for efficient ocular delivery
Pandian S
IET nanobiotechnology 2017; 11: 32-39
73056 Ocular surface disease in patients under topical treatment for glaucoma
Pérez-Bartolomé F
European Journal of Ophthalmology 2017; 0: 0
72840 Predicted patient demand for a new delivery system for glaucoma medicine
Ozdemir S
Medicine 2017; 96: e6626
73072 The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case
Battistini FD
European Journal of Pharmaceutical Sciences 2017; 105: 188-194
72930 Ocular Surface and External Filtration Surgery: Mutual Relationships
Baudouin C
Developments in Ophthalmology 2017; 59: 67-79
72967 Efficacy and tolerability of preservative-free 0.0015% tafluprost in glaucoma patients: a prospective crossover study
Lee S
BMC Ophthalmology 2017; 17: 61
72828 Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability
Bhagav P
Investigative Ophthalmology and Visual Science 2017; 58: 2167-2179
72837 Evaluation of Ocular Surface Disease in Asian Patients with Primary Angle Closure
Othman K
Open Ophthalmology Journal 2017; 11: 31-39
73010 RES-loaded pegylated CS NPs: for efficient ocular delivery
Jeevanesan V
IET nanobiotechnology 2017; 11: 32-39
73072 The role of hyaluronan as a drug carrier to enhance the bioavailability of extended release ophthalmic formulations. Hyaluronan-timolol ionic complexes as a model case
Tártara LI
European Journal of Pharmaceutical Sciences 2017; 105: 188-194
72633 Creation of nano eye-drops and effective drug delivery to the interior of the eye
Aoyagi S
Scientific reports 2017; 7: 44229
73056 Ocular surface disease in patients under topical treatment for glaucoma
Martínez-de-la-Casa JM
European Journal of Ophthalmology 2017; 0: 0
72840 Predicted patient demand for a new delivery system for glaucoma medicine
Wong TT
Medicine 2017; 96: e6626
